NCT04506593 Indiana University Gastrointestinal Motility Diagnosis Registry
| NCT ID | NCT04506593 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Indiana University |
| Condition | Eosinophilic Esophagitis |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2014-11 |
| Primary Completion | 2026-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2014-11 with a primary completion date of 2026-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Develop a registry (list of patients) with accurate clinical motility diagnosis. This registry will help the doctors to identify the patients with specific disease conditions. It will also help in promoting future research in gastroenterology motility disorders
Eligibility Criteria
Inclusion Criteria: 1. Patients who presented to the GI outpatient clinics, in-patient consult service, and outpatient endoscopy centers within the Division of Gastroenterology and Hepatology 2. Carries a diagnosis of GI motility disorder based on the diagnostic criteria listed in table Exclusion Criteria: 1\. Coexisting medical conditions that may limiting participation in clinical research trial
Contact & Investigator
John m Wo, MD
PRINCIPAL INVESTIGATOR
Indiana University
Frequently Asked Questions
Who can join the NCT04506593 clinical trial?
This trial is open to participants of all sexes, studying Eosinophilic Esophagitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04506593 currently recruiting?
Yes, NCT04506593 is actively recruiting participants. Contact the research team at larcohen@iu.edu for enrollment information.
Where is the NCT04506593 trial being conducted?
This trial is being conducted at Indianapolis, United States.
Who is sponsoring the NCT04506593 clinical trial?
NCT04506593 is sponsored by Indiana University. The principal investigator is John m Wo, MD at Indiana University. The trial plans to enroll 5,000 participants.